Heart-Focused Breathing in Alzheimer's Disease Caregivers

Sponsor
Arizona State University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT04077450
Collaborator
(none)
0
1
2
12
0

Study Details

Study Description

Brief Summary

This research study will explore the effects of an online heart-focused breathing intervention on 20 informal caregivers of patients with Alzheimer's Disease (AD) over a period of two weeks.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Online Heart-Focused Breathing Intervention
N/A

Detailed Description

Informal caregivers are often live-in, unpaid spouses, relatives, partners, or friends that help with a loved one's activities of daily living. As a result of caring for a person with Alzheimer's Disease (AD), many informal caregivers experience caregiver burden. The demanding physical, emotional, and financial responsibilities to care for an AD patient can be detrimental to the caregiver's health.

A group of 20 men and women who consider themselves the primary caregiver of a person with AD will be recruited and enrolled into the study. Participants will be randomized into one of two study arms, (a) the modified-waitlist control arm or (b) the intervention arm. The study will explore the effects of an online heart-focused breathing intervention on heart rate variability (measured by the Welltory app on their smart device), perceived burden, stress, and quality of life in the intervention arm over a two-week period.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized controlled trial in which participants will be randomized into (a) the modified waitlist-control arm or (b) the intervention arm.Randomized controlled trial in which participants will be randomized into (a) the modified waitlist-control arm or (b) the intervention arm.
Masking:
Single (Participant)
Masking Description:
Only participants will be blinded as to which study arm he or she was assigned.
Primary Purpose:
Treatment
Official Title:
Effectiveness of Heart-focused Breathing on Reducing Burden in Alzheimer's Caregivers: An Online Randomized Pilot Study
Actual Study Start Date :
Jan 28, 2019
Actual Primary Completion Date :
Jan 27, 2020
Actual Study Completion Date :
Jan 27, 2020

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Modified Waitlist Control Arm

Participants will complete the following components of baseline (T1) data collection: demographics, questionnaire, heart rate variability assessment. Two weeks later, participants will be asked to complete post-intervention data collection (T2), which consists of a questionnaire and heart rate variability assessment. After the completion of data collection, participants will be offered the online heart-focused breathing intervention.

Experimental: Intervention Arm

Participants will complete the following components of baseline (T1) data collection: demographics, questionnaire, heart rate variability assessment. These participants will receive an online heart-focused breathing intervention. Participants will be asked to practice their breathing skills while monitoring their heart rate variability using the Welltory app on their smart device for the following two weeks. Participants will be instructed to maintain a log to record the date and time of each practice session. Research staff will make biweekly reminder calls to participants. After the two-week period, participants will complete post-intervention data collection (T2), which includes a questionnaire and HRV assessment.

Behavioral: Online Heart-Focused Breathing Intervention
Participants will receive an online standardized HeartMath© heart-focused breathing intervention.

Outcome Measures

Primary Outcome Measures

  1. Caregiver Burden [2 weeks]

    Caregiver Burden will be measured by the Zarit Burden Interview short version (12 items, 5-point Likert scale; 0= never, 4= nearly always). Score range= 0 to 48. A score of 17 or higher indicates a high level of burden.

Secondary Outcome Measures

  1. Life Quality [2 weeks]

    Quality of Life will be measured by the Arizona Integrative Outcomes Scale (AIOS) (2-items, visual analogue scale; 0 millimeters= worst you have ever been, 100 millimeters= best you have ever been). Score range= 0 to 200. The AIOS asks participants to reflect on their sense of well-being over the past 24 hours and over the past month.

  2. Perceived Stress [2 weeks]

    Perceived Stress will be measured by the Perceived Stress Scale (PSS) (10 items, 5-point Likert scale; 0= never, 4= very often). Score range= 0 to 40. The PSS has a general score by combining all item scores and reverse scoring items 4, 5, 7, and 8. The PSS has two subscales, one for perceived distress (items 1, 2, 3, 6, 9, 10) and one for perceived coping (4, 5, 7, 8). A higher general score is associated with a higher level of stress.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male or female

  • 18 years of age or older

  • Live-in and unpaid informal caregiver to a loved one with Alzheimer's Disease

  • Provides care or supervision for at least 4 hours per day for more than 6 months

  • Experiencing stress

Exclusion Criteria:
  • Caregivers who report a low risk assessment score and/or report a medically diagnosed arrhythmia or have a pacemaker will be excluded

Contacts and Locations

Locations

Site City State Country Postal Code
1 Arizona State University Phoenix Arizona United States 85004

Sponsors and Collaborators

  • Arizona State University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Arizona State University
ClinicalTrials.gov Identifier:
NCT04077450
Other Study ID Numbers:
  • STUDY00009353
First Posted:
Sep 4, 2019
Last Update Posted:
Feb 25, 2020
Last Verified:
Feb 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Arizona State University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 25, 2020